ZBTB32 and neoplasm: As shown in Figure 2B, DGCR5 (DCGR10) expression was decreased in tissues from OS patients, resulting in decreased expression of ZBTB32. This observation further supports our hypothesis that DGCR5 (DCGR10) acts as a tumor suppressor.